Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021.
作者信息
Jones Christopher M, Han Beth, Baldwin Grant T, Einstein Emily B, Compton Wilson M
机构信息
National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.
National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
出版信息
JAMA Netw Open. 2023 Aug 1;6(8):e2327488. doi: 10.1001/jamanetworkopen.2023.27488.
Abstract
摘要
相似文献
1
Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021.2021年美国过去一年患有阿片类药物使用障碍的成年人中用于阿片类药物使用障碍的药物使用情况。
JAMA Netw Open. 2023 Aug 1;6(8):e2327488. doi: 10.1001/jamanetworkopen.2023.27488.
2
Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.2006 年至 2016 年期间，新发阿片类药物使用障碍或阿片类药物相关过量患者中，预先使用处方类阿片或辅助类镇痛药的趋势。
Drug Alcohol Depend. 2019 Nov 1;204:107600. doi: 10.1016/j.drugalcdep.2019.107600. Epub 2019 Sep 27.
3
Prescription opioid misuse among middle-aged and older adults in the United States, 2015-2016.美国中年和老年人 2015-2016 年处方阿片类药物滥用情况。
Prev Med. 2019 Apr;121:94-98. doi: 10.1016/j.ypmed.2019.02.018. Epub 2019 Feb 11.
4
Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder.美沙酮和丁丙诺啡在产后阿片类药物使用障碍妇女中的停药。
Am J Obstet Gynecol. 2021 Oct;225(4):424.e1-424.e12. doi: 10.1016/j.ajog.2021.04.210. Epub 2021 Apr 15.
5
Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder.在接受阿片类药物使用障碍治疗的成年人中，多种物质使用模式与阿片类药物使用障碍治疗药物的使用之间的关联。
J Addict Med. 2021 Apr 1;15(2):159-162. doi: 10.1097/ADM.0000000000000726.
6
Drug court utilization of medications for opioid use disorder in high opioid mortality communities.高阿片类死亡率社区药物法庭对治疗阿片类药物使用障碍药物的使用情况。
J Subst Abuse Treat. 2022 Oct;141:108850. doi: 10.1016/j.jsat.2022.108850. Epub 2022 Jul 29.
7
Prescription opioid misuse motive latent classes: outcomes from a nationally representative US sample.处方阿片类药物滥用动机潜在类别：来自全国代表性美国样本的结果。
Epidemiol Psychiatr Sci. 2020 Jan 29;29:e97. doi: 10.1017/S2045796020000037.
8
Age-related patterns in nonmedical prescription opioid use and disorder in the US population at ages 12-34 from 2002 to 2014.2002年至2014年美国12至34岁人群非医疗处方阿片类药物使用及成瘾的年龄相关模式。
Drug Alcohol Depend. 2017 Aug 1;177:237-243. doi: 10.1016/j.drugalcdep.2017.03.024. Epub 2017 May 24.
9
Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health.美国成年人的处方阿片类药物使用、滥用和使用障碍：2015 年全国毒品使用与健康调查。
Ann Intern Med. 2017 Sep 5;167(5):293-301. doi: 10.7326/M17-0865. Epub 2017 Aug 1.
10
Opioid misuse as a coping behavior for unmet mental health needs among U.S. adults.美国成年人将阿片类药物滥用作为满足心理健康需求的应对行为。
Drug Alcohol Depend. 2021 Aug 1;225:108805. doi: 10.1016/j.drugalcdep.2021.108805. Epub 2021 Jun 18.
引用本文的文献
1
Three trajectories of implementation of medications for opioid use disorder in primary care.基层医疗中阿片类物质使用障碍药物治疗的三种实施路径。
Addict Sci Clin Pract. 2025 Sep 1;20(1):69. doi: 10.1186/s13722-025-00600-y.
2
Collaborative Care for Opioid Use Disorder in Primary Care: A Hybrid Type 2 Cluster Randomized Clinical Trial.初级保健中阿片类物质使用障碍的协作式照护：一项2型混合整群随机临床试验
JAMA Psychiatry. 2025 Aug 20. doi: 10.1001/jamapsychiatry.2025.2126.
3
A mixed-method exploratory assessment of provider-based stigma of opioid use disorder (OUD) and support for medications for opioid use disorder (MOUD) in carceral settings.对监狱环境中基于提供者的阿片类药物使用障碍（OUD）污名化以及对阿片类药物使用障碍药物治疗（MOUD）支持情况的混合方法探索性评估。
Harm Reduct J. 2025 Aug 18;22(1):141. doi: 10.1186/s12954-025-01291-z.
4
Social and behavioral correlates of sleep health among adults receiving medication treatment for opioid use disorder.接受阿片类物质使用障碍药物治疗的成年人睡眠健康的社会和行为相关因素。
Addict Res Theory. 2025 Aug 6. doi: 10.1080/16066359.2025.2530997.
5
Addiction Consult Services, Mortality, and Acute Care Utilization in Inpatients With Opioid Use Disorder: A Secondary Analysis of a Cluster Randomized Clinical Trial.阿片类药物使用障碍住院患者的成瘾咨询服务、死亡率和急性护理利用情况：一项整群随机临床试验的二次分析
JAMA Netw Open. 2025 Aug 1;8(8):e2525222. doi: 10.1001/jamanetworkopen.2025.25222.
6
Primary Care Patients With Opioid Use Disorder Symptoms: Initiation and Engagement in Treatment With Medicine.有阿片类药物使用障碍症状的基层医疗患者：药物治疗的启动与参与情况
Ann Fam Med. 2025 Jul 28;23(4):308-314. doi: 10.1370/afm.240440.
7
On-site health service delivery models at syringe services programs in the United States: Results of a national cross-sectional survey.美国注射器服务项目的现场医疗服务提供模式：一项全国横断面调查的结果
Drug Alcohol Depend Rep. 2025 Jun 26;16:100355. doi: 10.1016/j.dadr.2025.100355. eCollection 2025 Sep.
8
Medicaid managed care organization service coverage and diagnosis and treatment of opioid use disorder: evidence from quasi-random auto-assignment in Kentucky.医疗补助管理式医疗组织对阿片类药物使用障碍的服务覆盖及诊断与治疗：来自肯塔基州准随机自动分配的证据
Health Aff Sch. 2025 Jun 11;3(7):qxaf119. doi: 10.1093/haschl/qxaf119. eCollection 2025 Jul.
9
Risk of self-harm and overdose after starting buprenorphine for opioid use disorder.开始使用丁丙诺啡治疗阿片类物质使用障碍后出现自我伤害和药物过量的风险。
Gen Hosp Psychiatry. 2025 Jun 24;96:90-96. doi: 10.1016/j.genhosppsych.2025.06.010.
10
Cannabis Legalization and Opioid Use Disorder in Veterans Health Administration Patients.退伍军人健康管理局患者中的大麻合法化与阿片类物质使用障碍
JAMA Health Forum. 2025 Jun 7;6(6):e251369. doi: 10.1001/jamahealthforum.2025.1369.
本文引用的文献
1
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.医疗保险受益人的远程医疗服务的接受情况、阿片类药物使用障碍药物的获得和保留情况，以及在 COVID-19 大流行之前和期间的药物治疗过量情况。
JAMA Psychiatry. 2022 Oct 1;79(10):981-992. doi: 10.1001/jamapsychiatry.2022.2284.
2
Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.2019 年美国需要阿片类药物治疗的青少年和成年人中，阿片类药物使用障碍药物治疗的使用情况。
JAMA Netw Open. 2022 Mar 1;5(3):e223821. doi: 10.1001/jamanetworkopen.2022.3821.
Zotero 插件